(Circulation. 2000;102:2973.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Risks of Morbidity and Mortality in Dialysis Patients Undergoing Coronary Artery Bypass Surgery
From the Departments of Surgery, Medicine, Community and Family Medicine, and the Center for the Evaluative and Clinical Sciences (J.Y.L., N.J.O.B., J.H.S., H.F.H., R.W.D., A.W.D., G.T.O.), Dartmouth-Hitchcock Medical Center, Lebanon, NH; the Department of Surgery (J.R.M.), Maine Medical Center, Portland; the Department of Surgery (S.J.L.), Beth Israel-Deaconess Medical Center, Boston, Mass; the Department of Surgery (C.M.), Optima Health (Catholic Medical Center), Manchester, NH; the Department of Surgery (R.C.), Eastern Maine Medical Center, Bangor, Maine; and the Department of Surgery (B.J.L.), Fletcher-Allen Health Care, Burlington, Vt.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Although dialysis patients are undergoing CABG with increasing frequency, large studies specifically comparing patient characteristics and procedure-related risks in this population have not been performed.
Methods and Results—We conducted a regional prospective cohort study of 15 500 consecutive patients undergoing CABG in northern New England from 1992 to 1997. We used multiple logistic regression analysis to examine associations between preoperative dialysis-dependent renal failure and postoperative events and to adjust for potentially confounding variables. The 279 dialysis-dependent renal failure patients (1.8%) were 4.4 times more likely to experience in-hospital mortality than were other CABG patients (12.2% versus 3.0%, respectively; P<0.001). Dialysis-dependent renal failure patients were older and had more comorbidities and more severe cardiac disease than did other CABG patients. After adjusting for these factors in multivariate analysis, however, dialysis-dependent renal failure patients remained 3.1 times more likely to die after CABG (adjusted odds ratio [OR] 3.1, 95% CI 2.1 to 4.7; P<0.001). Dialysis-dependent renal failure patients compared with other CABG patients also had a substantially increased risk of postoperative mediastinitis (3.6% versus 1.2%, respectively; adjusted OR 2.4, 95% CI 1.2 to 4.7; P=0.011) and postoperative stroke (4.3% versus 1.7%, respectively; adjusted OR 2.1, 95% CI 1.1 to 3.9; P=0.016), even after controlling for potentially confounding variables. Risks of reexploration for bleeding were similar for patients with and without dialysis-dependent renal failure.
Conclusions—Preoperative dialysis-dependent renal failure is a strong independent risk factor for in-hospital mortality and mediastinitis after CABG.
Key Words: kidney • mortality • morbidity • bypass
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patients with chronic renal failure have a high prevalence of coronary artery disease and cardiovascular death. Cardiac risks are particularly high in dialysis-dependent renal failure patients. Published reports indicate a 30% to 53% increase in death due to coronary artery disease in dialysis-dependent renal failure patients, which is unchanged over the past 10 years.1 With the increasing use of renal replacement therapy (transplant, hemodialysis, and peritoneal dialysis), especially in the older populations, efforts are being made to improve long-term survival.2 3 For these reasons, dialysis-dependent renal failure patients are considered for myocardial revascularization procedures. Because the results of PTCA have been shown to be relatively poor for this population,4 patients are recommended for CABG with increasing frequency.5 6 7
Despite the increasing use of CABG among dialysis-dependent renal failure patients, procedure-related risks in this population are not well understood. A number of studies have identified indicators of preoperative impaired renal function as risk factors for mortality8 9 10 11 12 and morbidity11 12 13 14 15 with CABG. However, prior studies specifically assessing patient characteristics and perioperative risks among patients with dialysis-dependent renal failure have been small single-institution case series.2 3 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
We conducted a regional cohort study of 15 550 patients undergoing CABG in northern New England from 1992 to 1997 to clarify the association between dialysis-dependent renal failure and in-hospital morbidity and mortality with CABG.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Subjects
The Northern New England Cardiovascular Disease Study Group is a voluntary research consortium representing all 5 medical centers in Maine, New Hampshire, and Vermont and 1 center in Massachusetts where CABG surgery is performed. Since 1987, the Northern New England Cardiovascular Disease Study Group has maintained a prospective registry of all patients undergoing CABG surgery in the region. For this analysis, we excluded patients undergoing CABG surgery incidental to heart valve repair, resection of ventricular aneurysm, or another surgical procedure.
Data Collection
The following data were recorded prospectively
for all patients: age, sex, height, weight, cardiac
catheterization results (degree of left main
coronary artery stenosis, total number of significantly
diseased coronary arteries, left ventricular
end-diastolic pressure, and ejection fraction), prior
cardiac surgery (CABG, PTCA, or valve procedure), PTCA during the
current admission, unstable angina during the current admission, prior
myocardial infarction, comorbidities (diabetes, peripheral
vascular disease, renal failure, chronic obstructive pulmonary
disease, congestive heart failure, cancers, and liver disease),
ischemia treatment factors (preoperative intra-aortic balloon
pump, preoperative intravenous
nitroglycerin therapy, and preoperative
thrombolytic therapy), priority of surgery (emergent,
urgent, or elective), and in-hospital outcomes (status at hospital
discharge [dead or alive], intraoperative or postoperative stroke
[yes or no], reoperation for bleeding [yes or no], and sternal
wound infection [yes or no]).
Cardiac catheterizations were performed by use of standard methods during the course of regular clinical care. The number of diseased coronary vessels was assessed by use of criteria established by the National Heart, Lung, and Blood Institute Coronary Artery Surgery Study.32 Priority of surgery was assessed by the cardiothoracic surgeons and is defined as follows: "emergency" means that medical factors relating to the patient’s cardiac disease dictate that surgery should be performed within hours to prevent morbidity or death, "urgent" means that medical factors require that the patient remain in the hospital before surgery, and "elective" means that medical factors indicate the need for operation, but the clinical situation allows discharge from the hospital with readmission for surgery at a later date.
Dialysis-dependent renal failure, defined by the preoperative use of hemodialysis or peritoneal dialysis, was determined prospectively. Patients in whom dialysis was initiated after surgery were included in the other CABG population, not in the dialysis-dependent renal failure group.
Postoperative bleeding was defined as bleeding that required surgical reexploration after initial departure from the operating room. Postoperative stroke was defined as a new neurological event occurring postoperatively that persisted for >24 hours after its onset and was noted before discharge. Mediastinitis was defined as a sternal infection requiring antibiotics and return to the operating room for sternal debridement.
Analysis
Candidate predictor variables were selected from
the core variables (age, sex, previous heart operation, left
ventricular ejection fraction, percent stenosis of
the left main coronary artery, number of major coronary
arteries with stenosis >70%, and priority of surgery), level
I variables (height, weight, PTCA on current admission, date of
most recent myocardial infarction, angina history [including use of
preoperative intra-aortic balloon pump, nitroglycerin,
and thrombolytics], congestive heart failure, and
chronic obstructive pulmonary disease), and available level II
variables (left ventricular end-diastolic
pressure, liver disease, and malignancy), which are suggested for risk
adjustment of in-hospital CABG outcomes by Jones et
al33 and the American College
of Cardiology/American Heart Association practice
guidelines.34 Core
variables have been shown to be unequivocally related to operative
mortality. Level I variables are likely related to short-term CABG
mortality, and level II variables are not clearly shown to relate
to short-term CABG mortality but are thought to be of research
interest. In our multivariate analyses, we did
not include the level I variables that are potentially in the
causal pathway between renal failure and adverse outcomes of CABG,
including diabetes, peripheral vascular disease, and
creatinine. In addition, serious ventricular
arrhythmias and mitral regurgitation are level
I variables that were not included in our analysis because
they are not available in our CABG data registry.
Univariate analyses involving
2 tests for categorical variables and
t tests for continuous
variables were performed to assess the statistical significance of
observed differences in patient characteristics between patients with
and without dialysis-dependent renal
failure.35 We used logistic
regression analysis to assess the effect of dialysis-dependent
renal failure on each outcome (expressed in terms of odds ratios
[ORs], which approximate relative risk) after adjustment for
potentially confounding
variables.36 The C
statistic (equivalent to the area under the receiver operating
characteristic curve) and the Lemeshow-Hosmer goodness of fit
statistic36 were
calculated to assess the performance and calibration of each
model, respectively. Analysis was performed by use of Stata
release 5.0
software.37
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Characteristics
Table 1
lists patient clinical and treatment factors
based on the presence or absence of dialysis-dependent renal failure.
Overall, 279 of the 15 500 patients (1.8%) had dialysis-dependent
renal failure before surgery. Dialysis-dependent renal failure patients
versus other CABG patients were older (66.7 versus 64.8 years,
P=0.005) and had a slightly
lower body surface area (1.9 versus 2.0 m2,
P<0.001). Males made up 66.3%
of the dialysis-dependent renal failure patients compared with 72.0%
of the other CABG patients. Dialysis-dependent renal failure patients
versus other CABG patients had more comorbid conditions including the
following: diabetes (48.0% versus 28.2%,
P<0.001),
peripheral vascular disease (40.9% versus 12.5%,
P<0.001), and chronic
obstructive pulmonary disease (27.2% versus 11.8%,
P<0.001). There were no
statistically significant differences between the 2 groups with regard
to liver disease or malignancy. On average, dialysis-dependent renal
failure patients versus other CABG patients had lower ejection
fractions (47.6% versus 53.5%,
P<0.001) and higher left
ventricular end-diastolic pressure (20.0 versus
16.9 mm Hg, P=0.001). In
addition, dialysis-dependent renal failure patients versus other CABG
patients were more likely to have a history of congestive heart failure
(37.3% versus 12.4%,
P<0.001), a prior history of a
myocardial infarction (65.5% versus 50.8%,
P<0.001), and unstable angina
(57.7% versus 48.1%, P=0.002)
and were more likely to receive treatment with preoperative
intravenous nitroglycerin (28.7% versus
20.1%, P<0.001) and
thrombolytics (6.8% versus 3.6%,
P=0.004). There was not a
statistically significant difference between dialysis patients and
other CABG patients in rates of use of preoperative intra-aortic
balloon pump or PTCA during the current admission. Dialysis patients
versus nondialysis patients had a higher number of diseased
coronary vessels (2.6 versus 2.4,
P<0.001), and more dialysis
patients underwent an urgent/emergent surgical procedure (70.6% versus
63.8%, P=0.018). However,
nondialysis patients were slightly more likely to have had a prior CABG
(22.6% versus 17.6%,
P=0.046), and there was no
difference in left main coronary artery disease between the 2
groups.
|
Patient Outcomes
The incidence of in-hospital mortality after CABG
surgery was 12.2% in the dialysis-dependent renal failure population
and 3.0% in the other CABG patients
(P<0.001). Mediastinitis
developed in 3.6% of the dialysis-dependent renal failure patients
versus 1.2% of the other CABG patients
(P<0.001). Stroke was observed
in 4.3% of the dialysis-dependent renal failure patients and 1.7% of
the other CABG patients
(P=0.001). Dialysis-dependent
renal failure patients had higher rates of return to the operating room
for bleeding than did other CABG patients (3.6% versus 2.9%), but
this difference was not statistically significant
(P=0.478).
The results from both univariate and
multivariate logistic models are presented in
Table 2. Dialysis-dependent renal failure patients were 4.4
times more likely to experience in-hospital mortality than were the
other CABG patients (OR 4.4, 95% CI 3.0 to 6.4;
P<0.001). After adjusting for
confounding variables, dialysis remained an important predictor of
in-hospital mortality with an OR of 3.1 (95% CI 2.1 to 4.7,
P<0.001). After adjustment was
made for confounding variables, dialysis-dependent renal failure
patients still had a 2.4 times higher rate of mediastinitis compared
with the nondialysis CABG population (OR 2.4, 95% CI 1.2 to 4.7;
P=0.011). Similarly, dialysis
patients compared with nondialysis CABG patients were 2.1 times more
likely to suffer a stroke after adjustment was made for confounding
variables (OR 2.1, 95% CI 1.1 to 3.9;
P=0.016) Dialysis-dependent
renal failure was not significantly associated with increased risk of
reexploration for bleeding in either univariate
analysis (OR 1.3, 95% CI 0.67 to 2.4;
P=0.478) or
multivariate analysis (OR 1.3, 95% CI 0.69 to
2.5; P=0.4.1).
|
Adjusted outcome rates are compared for dialysis and
nondialysis patients in the
Figure.
The adjusted in-hospital mortality rate is 9.6% for dialysis-dependent
renal failure patients versus 3.1% for other CABG patients
(P<0.001). With regard to
mediastinitis, the dialysis-dependent renal failure patients had an
adjusted rate of 3.1% compared with 1.2% for nondialysis CABG
patients (P=0.011). The
difference in adjusted stroke rate between dialysis and nondialysis
patients was significant (3.7% versus 1.7%,
P=0.016). Adjusted rates for
bleeding were similar for dialysis-dependent renal failure patients and
nondialysis patients (3.8% versus 2.9%,
P=0.401).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Preoperative dialysis dependence is an important independent predictor of in-hospital mortality, mediastinitis, and stroke for patients undergoing CABG. In this region, 279 dialysis-dependent renal failure patients underwent CABG between 1992 and 1996 (1.8% of CABG patients). In univariate analysis, the risk of death was 4.4 times higher (12.2% versus 3.0%), the risk of mediastinitis was 3.1 times higher (3.6% versus 1.2%), and the risk of stroke was 2.6 times higher (4.3% versus 1.7%) for the dialysis patients versus the nondialysis patients. However, dialysis patients were older, had a higher prevalence of comorbid conditions, and had more severe cardiac disease before surgery than did nondialysis CABG patients. After adjustment for these factors, risks of mortality, mediastinitis, and stroke remained 3.1, 2.4, and 2.1 times higher, respectively, among dialysis patients. We observed no significant relationship between dialysis-dependent renal failure and the risk of postoperative bleeding in either univariate or multivariate analysis.
A number of studies have identified indicators of preoperative impaired renal function as risk factors for mortality8 9 10 11 12 and morbidity11 12 13 14 15 with CABG. In a prior study from this group, preexisting renal failure was present in 1.2% of patients undergoing CABG and was associated with 5.2 times greater risk of in-hospital mortality.8 In the Veterans Administration Risk Assessment Study for Cardiac Surgery, preoperative creatinine levels were positively associated with risks of mortality in univariate analysis10 and with complications in multivariate analysis.13 A more recent study in the VA population found that mild renal failure (serum creatinine >1.5 mg/dL) was associated with 30-day mortality, postoperative bleeding, and ventilatory complications in multivariate analyses.12 A retrospective analysis of patients undergoing CABG at the Cleveland Clinic found that patients with preoperative serum creatinine levels >168 µmol/L had higher perioperative morbidity (OR 2.8) and mortality (OR 3.7) in multivariate analysis.11 Similar to the results of the present study, preoperative dialysis dependence was independently associated with an increased risk of in-hospital mortality (OR 3.2) among CABG patients in New York State.9 Another study from the state of New York identified renal failure (creatinine >2.5 mg/dL or on dialysis) as an independent risk factor for postoperative stroke (OR 2.0).15 Chronic renal failure has also been linked to higher rates of morbidity and mortality in numerous case series.2 3 14 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
A number of theories about the mechanisms for increased morbidity and mortality among renal failure patients undergoing surgery have been proposed. Dialysis-dependent renal failure patients are an immune compromised population, and this may contribute to their increased risk of postoperative infection. For example, dialysis-dependent renal failure patients have a higher wound infection rate after lower extremity bypass.38 Whether increased infection rates are due to uremia, diabetes, steroid use secondary to autoimmune causes of renal failure, and other variables that are known to increase the risk of infection is unknown. Dialysis patients are also chronically anemic from the loss of erythropoietin production by the kidneys,39 40 and anemia has been shown to be associated with increased risks of mortality among CABG patients.41 Platelet dysfunction and coagulation defects from uremia are cited as mechanisms for increased bleeding among patients on dialysis,23 and renal failure may serve as a marker for generalized arteriosclerosis predisposing to thromboembolic events and stroke,15 as well as to less adequate revascularization and the development of postoperative low-output syndrome.3
It is important to consider both the strengths and limitations of the present study. The strengths of our study include prospective data collection on a regional level such that biases in the collection of data or selection of study participants should not be limitations. Random misclassification of the primary exposure variable (dialysis dependence) is unlikely but would only result in an underestimate of the true relationship between dialysis-dependent renal failure and adverse outcomes if it occurred. The present study had adequate power to detect the differences between dialysis and nondialysis patients in the occurrence of adverse events while controlling for confounding variables due to the large size of the study population. In addition, our data registry contained detailed information from which to base risk-adjustment models. These models were well calibrated and had reasonable performance characteristics, so confounding by patient case mix should also not be a serious concern. Although some residual confounding from unmeasured or inaccurately recorded variables is likely, it is implausible that differences of the magnitude noted herein are completely explained by this cause. For this to be responsible for the entire effect observed, the confounder(s) would have to be a strong predictor(s) of outcome, substantially uncorrelated with known predictors that were considered, and unequally distributed among dialysis and nondialysis patients.
Dialysis-dependent renal failure patients are in general older and burdened with more comorbidities than are other patients undergoing CABG. They are at an increased risk for mortality, mediastinitis, and stroke. However, we have found no significant increase in rates of return to the operating room for bleeding among dialysis-dependent renal failure patients after adjustment for potentially confounding variables. These results should be considered when discussing surgical risks with dialysis-dependent renal failure patients.
|
Footnotes |
|---|
Reprint requests to Dr Jean Y. Liu, VA Outcomes Group (111B), Department of Veterans Affairs Hospital, White River Junction, VT 05009.
The views expressed herein do not necessarily represent those of the Department of Veterans Affairs or the US government.
Received March 17, 2000; revision received July 18, 2000; accepted July 31, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Wing AJ, Broyer M, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc. 1983;20:2–75.[Medline] [Order article via Infotrieve]
2. Owen CH, Cummings RG, Sell TL, et al. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg. 1994;58:1729–1733.[Abstract]
3. Rao V, Weisel RD, Buth KJ, et al. Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation. 1997;96(suppl II):II-38–II-45.
4. Rinehart AL, Herzog CA, Collins AJ, et al. A comparison of coronary angiography and coronary artery bypass grafting outcomes in chronic dialysis dependent renal failure patients. Am J Kidney Dis. 1995;25:281–290.[Medline] [Order article via Infotrieve]
5. Cruz DN, Bia MJ. Coronary revascularization in patients on dialysis: what treatment options should we choose? ASAIO J. 1996;42:139–141.[Medline] [Order article via Infotrieve]
6. Simsir SA, Kohlman-Trigoboff D, Flood R, et al. A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis. Cardiovasc Surg. 1998;6:500–505.[Medline] [Order article via Infotrieve]
7. Kahn JK, Rutherford BD, McConahay DR, et al. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J. 1990;119:484–489.[Medline] [Order article via Infotrieve]
8.
O’Connor GT, Plume
SK, Olmstead EM, et al. Multivariate prediction of
in-hospital mortality associated with coronary bypass surgery.
Circulation. 1992;85:2110–2118.
9.
Hannan EL, Kilburn
H, O’Donnell JF, et al. Adult open heart surgery in New York State: an
analysis of risk factors and hospital mortality rates.
JAMA. 1990;264:2768–2774.
10. Grover F, Hammermeister KE, Burchfiel C. Initial report of the Veterans Administration pre-operative risk assessment study for cardiac surgery. Ann Thorac Surg. 1990;50:12–28.[Abstract]
11.
Higgins TL,
Estafanous FG, Loop FD, et al. Stratification of morbidity and
mortality outcome by pre-operative risk factors in coronary
artery bypass patients: a clinical severity score.
JAMA. 1992;267:2344–2348.
12. Anderson R, O’Brien M, MaWhinney S, et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery: VA Cooperative Study #5. Kidney Int. 1999;55:1057–1062.[Medline] [Order article via Infotrieve]
13. Hammermeister KE, Burchfiel C, Johnson R, et al. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation. 1990;82(suppl IV):IV-380–IV-389.
14.
Kurki TSO, Kataja
M. Pre-operative prediction of postoperative morbidity in
coronary artery bypass grafting.
Ann Thorac Surg. 1996;61:1740–1745.
15.
John R, Choudhri
AF, Weinberg AD, et al. Multicenter review of pre-operative risk
factors for stroke after coronary artery bypass grafting.
Ann Thorac Surg. 2000;69:30–36.
16. Zamora JL, Burdine JT, Karlberg H, et al. Cardiac surgery in patients with end-stage renal disease. Ann Thorac Surg. 1986;42:113–117.[Abstract]
17. Samuels LE, Sharma S, Morris RJ, et al. Coronary artery bypass grafting in patients with chronic renal failure: a reappraisal. J Card Surg. 1996;11:128–133.[Medline] [Order article via Infotrieve]
18. Rostand S, Kirk K, Rutsky E, et al. Results of coronary artery bypass grafting in end stage renal disease. Am J Kidney Dis. 1988;12:266–270.[Medline] [Order article via Infotrieve]
19. Peper WA, Taylor PC, Paganini EP, et al. Mortality and results after cardiac surgery in patients with end-stage renal disease. Cleve Clin J Med. 1988;55:63–67.[Medline] [Order article via Infotrieve]
20. Opsahl JA, Husebye DG, Helseth HK, et al. Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival. Am J Kidney Dis. 1988;12:271–274.[Medline] [Order article via Infotrieve]
21. Marshall WG, Rossi NP, Meng RL, et al. Coronary artery bypass grafting in dialysis dependent renal failure patients. Ann Thorac Surg. 1986;42(suppl):S12–S15.
22. Koyanagi T, Nishida H, Endo M, et al. Coronary artery bypass grafting in chronic renal dialysis patients: intensive perioperative dialysis and extensive usage of arterial grafts. Eur J Cardiothorac Surg. 1994;8:505–507.[Abstract]
23.
Jahangiri M,
Wright J, Edmondson S, et al. Coronary artery bypass surgery in
dialysis dependent renal failure patients.
Heart. 1997;78:343–345.
24.
Horst M, Mehlhorn
E, Hoerstrup SP, et al. Cardiac surgery in patients with end-stage
renal disease: 10 year experience. Ann
Thorac Surg. 2000;69:96–101.
25. Ashraf SS, Shaukat N, Kamaly ID, et al. Determinants of early and late mortality in patients with end-stage renal disease undergoing cardiac surgery. Scand J Thorac Cardiovasc Surg. 1995;29:187–193.[Medline] [Order article via Infotrieve]
26. Batiuk TD, Kurtz SB, Oh JK, et al. Coronary artery bypass operation in dialysis dependent renal failure patients. Mayo Clin Proc. 1991;66:45–53.[Medline] [Order article via Infotrieve]
27. Blum U, Skupin M, Wagner R, et al. Early and long-term results of cardiac surgery in dialysis dependent renal failure patients. Cardiovasc Surg. 1994;2:97–100.[Medline] [Order article via Infotrieve]
28. DeMeyer M, Wyns W, Dion R, et al. Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol. 1991;36:147–151.[Medline] [Order article via Infotrieve]
29. Deutsch E, Bernstein RC, Addonizio VP, et al. Coronary artery bypass surgery in patients on chronic hemodialysis. Ann Intern Med. 1989;110:369–372.
30.
Frenken M, Krian
A. Cardiovascular operations in patients with
dialysis-dependent renal failure. Ann
Thorac Surg. 1999;68:887–893.
31. Kaul TK, Fields BL, Reddy MA, et al. Cardiac operations in patients with end-stage renal disease. Ann Thorac Surg. 1994;57:691–696.[Abstract]
32. The Principal Investigators of CASS and their Associates. The National Heart, Lung, and Blood Institute Coronary Artery Surgery Study (CASS). Circulation. 1981;63(suppl):1–81.
33. Jones RH, Hannan EL, Hammermeister KE, et al. Identification of pre-operative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. J Am Coll Cardiol. 1996;28:1478–1487.[Abstract]
34. ACC/AHA. ACC/AHA practice guidelines for coronary artery bypass graft surgery. J Am Coll Cardiol. 1999;34:1263–1347.
35. Dawson-Saunders B, Trapp R. Basic and Clinical Biostatistics. Norwalk, Conn: Appleton & Lange; 1990.
36. Hosmer D, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
37. Statacorp. STATA Statistical Software: Release 5.0 Edition. College Station, Tex: Stata Corp; 1997.
38. Johnson BL, Glickman MH, Bandyk DF, et al. Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J Vasc Surg. 1995;22:280–286.[Medline] [Order article via Infotrieve]
39.
Pastan S, Bailey
J. Dialysis therapy. N Engl J
Med. 1998;338:1428–1437.
40.
Morbidity and
mortality of renal dialysis: an NIH consensus conference statement.
Ann Intern Med. 1994;121:62–70.
41. DeFoe G, Ross C, Olmstead E, et al. Low hematocrit on bypass pump and adverse outcomes during coronary artery bypass surgery. Circulation. 1998;98(suppl I):I-613. Abstract.
This article has been cited by other articles:
 |
|
 |
|
  Y. Lin, Z. Zheng, Y. Li, X. Yuan, J. Hou, S. Zhang, H. Fan, Y. Wang, W. Li, and S. Hu Impact of Renal Dysfunction on Long-Term Survival After Isolated Coronary Artery Bypass Surgery Ann. Thorac. Surg., April 1, 2009; 87(4): 1079 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. F. Nevis, A. Mathew, R. J. Novick, C. R. Parikh, P. J. Devereaux, M. K. Natarajan, A. V. Iansavichus, M. S. Cuerden, and A. X. Garg Optimal Method of Coronary Revascularization in Patients Receiving Dialysis: Systematic Review Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 369 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Filsoufi, J. Chikwe, J. G. Castillo, P. B. Rahmanian, J. Vassalotti, and D. H. Adams Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3613 - 3621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Rahmanian, D. H. Adams, J. G. Castillo, J. Vassalotti, and F. Filsoufi Early and late outcome of cardiac surgery in dialysis-dependent patients: Single-center experience with 245 consecutive patients. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 915 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Horai, T. Fukui, M. Tabata, and S. Takanashi Early and mid-term results of off-pump coronary artery bypass grafting in patients with end stage renal disease: surgical outcomes after achievement of complete revascularization Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 218 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.F. M. Bechtel, C. Detter, T. Fischlein, T. Krabatsch, B. R. Osswald, F.-C. Riess, F. Scholz, M. Schonburg, C. Stamm, H.-H. Sievers, et al. Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival Ann. Thorac. Surg., January 1, 2008; 85(1): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Brown, T. M. Sundt III, and B. J. Gersh Indications for Revascularization Card. Surg. Adult, January 1, 2008; 3(2008): 551 - 572. [Full Text]
|
|
|
|
 |
|
 S. Mohammadi, F. Dagenais, P. Mathieu, J. G. Kingma, D. Doyle, S. Lopez, R. Baillot, J. Perron, E. Charbonneau, E. Dumont, et al. Long-Term Impact of Diabetes and Its Comorbidities in Patients Undergoing Isolated Primary Coronary Artery Bypass Graft Surgery Circulation, September 11, 2007; 116(11_suppl): I-220 - I-225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Chonchol, V. Aboyans, P. Lacroix, G. Smits, T. Berl, and M. Laskar Long-term outcomes after coronary artery bypass grafting: Preoperative kidney function is prognostic J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 683 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Charytan and R. E. Kuntz Risks of coronary artery bypass surgery in dialysis-dependent patients--analysis of the 2001 National Inpatient Sample Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1665 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mazzoni, R. De Maria, F. Bortone, M. Parolini, R. Ceriani, C. Solinas, V. Arena, and O. Parodi Long-Term Outcome of Survivors of Prolonged Intensive Care Treatment After Cardiac Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2080 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Sarafidis and G. L. Bakris Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374. [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cooper, S. M. O'Brien, V. H. Thourani, R. A. Guyton, C. R. Bridges, L. A. Szczech, R. Petersen, and E. D. Peterson Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass Surgery: Results From the Society of Thoracic Surgeons National Adult Cardiac Database Circulation, February 28, 2006; 113(8): 1063 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Hillis, B. L. Croal, K. G. Buchan, H. El-Shafei, G. Gibson, R. R. Jeffrey, C. G.M. Millar, G. J. Prescott, and B. H. Cuthbertson Renal Function and Outcome From Coronary Artery Bypass Grafting: Impact on Mortality After a 2.3-Year Follow-Up Circulation, February 28, 2006; 113(8): 1056 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rahbar, W. R. McGee, T. J. Birdas, S. Muluk, J. Magovern, and T. Maher Upper Extremity Arteriovenous Fistulas Induce Modest Hemodynamic Effect on the In Situ Internal Thoracic Artery Ann. Thorac. Surg., January 1, 2006; 81(1): 145 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Holzmann, S. Ahnve, N. Hammar, L. Jorgensen, K. Klerdal, K. Pehrsson, and T. Ivert Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 746 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Witczak, A. Hartmann, and J. L. Svennevig Multiple Risk Assessment of Cardiovascular Surgery in Chronic Renal Failure Patients Ann. Thorac. Surg., April 1, 2005; 79(4): 1297 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tabata, S. Takanashi, T. Fukui, T. Horai, T. Uchimuro, K. Kitabayashi, and Y. Hosoda Off-Pump Coronary Artery Bypass Grafting in Patients With Renal Dysfunction Ann. Thorac. Surg., December 1, 2004; 78(6): 2044 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Trachiotis, D. Hanumara, L. McKenna, P. Corso, and A. Pfister Surgical revascularization after acute myocardial infarction in patients with end-stage renal disease Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 671 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Leavitt, L. Sheppard, C. Maloney, R. A. Clough, J. H. Braxton, D. C. Charlesworth, R. M. Weintraub, F. Hernandez, E. M. Olmstead, W. C. Nugent, et al. Effect of Diabetes and Associated Conditions on Long-Term Survival After Coronary Artery Bypass Graft Surgery Circulation, September 14, 2004; 110(11_suppl_1): II-41 - II-44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Choi, K. L. Kim, W. Huh, B. Kim, J. Byun, W. Suh, J. Sung, E.-S. Jeon, H.-Y. Oh, and D.-K. Kim Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1246 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Srinivasan, A. Y. Oo, A. D. Grayson, R. Lowe, R. A. Perry, B. M. Fabri, and A. Rashid Mid-term survival after cardiac surgery in elderly patients: analysis of predictors for increased mortality Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 289 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Gibson, D. S. Pinto, S. A. Murphy, D. A. Morrow, H.-P. Hobbach, S. D. Wiviott, R. P. Giugliano, C. P. Cannon, E. M. Antman, E. Braunwald, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1535 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Reinecke and R. M. Schaefer Percutaneous coronary interventions in patients with mild to moderate chronic renal failure: to dilate or not to dilate? Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2218 - 2221. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Herzog How to Manage the Renal Patient with Coronary Heart Disease: The Agony and the Ecstasy of Opinion-Based Medicine J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2556 - 2572. [Full Text] [PDF]
|
|
|
|
|
|
D. Wong, G. Thompson, K. Buth, J. Sullivan, and I. Ali Angiographic coronary diffuseness and outcomes in dialysis patients undergoing coronary artery bypass grafting surgery Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 388 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Reddan, L. A. Szczech, R. H. Tuttle, L. K. Shaw, R. H. Jones, S. J. Schwab, M. S. Smith, R. M. Califf, D. B. Mark, and W. F. Owen Jr. Chronic Kidney Disease, Mortality, and Treatment Strategies among Patients with Clinically Significant Coronary Artery Disease J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2373 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Freeman, R. H. Mehta, W. Al Badr, J. V. Cooper, E. Kline-Rogers, and K. A. Eagle Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors J. Am. Coll. Cardiol., March 5, 2003; 41(5): 718 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yellin, Y. Refaely, M. Paley, and D. Simansky Major bleeding complicating deep sternal infection after cardiac surgery J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 554 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Herzog, J. Z. Ma, and A. J. Collins Comparative Survival of Dialysis Patients in the United States After Coronary Angioplasty, Coronary Artery Stenting, and Coronary Artery Bypass Surgery and Impact of Diabetes Circulation, October 22, 2002; 106(17): 2207 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Dacey, J. Y. Liu, J. H. Braxton, R. M. Weintraub, J. DeSimone, D. C. Charlesworth, S. J. Lahey, C. S. Ross, F. Hernandez Jr, B. J. Leavitt, et al. Long-term survival of dialysis patients after coronary bypass grafting Ann. Thorac. Surg., August 1, 2002; 74(2): 458 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Gardlund, C.Y. Bitkover, and J. Vaage Postoperative mediastinitis in cardiac surgery -- microbiology and pathogenesis Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 825 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Khuri Evidence, sources, and assessment of injury during and following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2205 - 2207. [Full Text] [PDF]
|
|
|
|
|
|
V. Birjiniuk Patient outcomes in the assessment of myocardial injury following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2208 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Combes, J.-L. Trouillet, J. Baudot, M. Mokhtari, J. Chastre, and C. Gibert Is it possible to cure mediastinitis in patients with major postcardiac surgery complications? Ann. Thorac. Surg., November 1, 2001; 72(5): 1592 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G Jardine and K. McLaughlin GENERAL CARDIOLOGY: Cardiovascular complications of renal disease Heart, October 1, 2001; 86(4): 459 - 466. [Full Text] [PDF]
|
|
|
|
 |
|
 Increased Risk Among Renal Failure Patients Undergoing Revascularization Journal Watch (General), January 9, 2001; 2001(109): 4 - 4. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||